페닐케톤뇨증(PKU) 유전자 검사 시장 규모, 점유율, 성장 분석 : 검사 유형별, 기술별, 검체 유형별, 최종사용자별, 용도별, 지역별 - 산업 예측(2026-2033년)

Global Phenylketonuria Genetic Testing Market size was valued at USD 1.84 Billion in 2024 and is poised to grow from USD 2.02 Billion in 2025 to USD 4.2 Billion by 2033, growing at a CAGR of 9.6% during the forecast period (2026-2033).

The global phenylketonuria (PKU) genetic testing market is primarily focused on diagnostic services and kits that detect mutations in the PAH gene linked to this metabolic disorder. With PKU significantly affecting neurodevelopment, early dietary intervention post-newborn screening is crucial. The market has evolved from enzymatic assays to advanced DNA-based detection methods, particularly through the use of tandem mass spectrometry in newborn screening programs. Current trends include the introduction of multiplex newborn panels that enhance payer acceptance and drive growth. An increasing demand for personalized nutrition based on genotype is a key driver, alongside insurers reimbursing molecular panels. Additionally, AI is enhancing market dynamics by improving data interpretation and accelerating testing processes, leading to greater efficiency, reduced costs, and broader access to genetic testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Phenylketonuria Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Phenylketonuria Genetic Testing Market Segments Analysis

Global phenylketonuria genetic testing market is segmented by test type, technology, sample type, end user, application and region. Based on test type, the market is segmented into Newborn Screening, Carrier Testing, Prenatal Testing and Diagnostic Testing. Based on technology, the market is segmented into PCR, Next-Generation Sequencing, Sanger Sequencing and Microarray. Based on sample type, the market is segmented into Blood, Amniotic Fluid and Buccal Cells. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories and Genetic Testing Centers. Based on application, the market is segmented into Diagnosis, Carrier Identification, Prenatal Assessment and Treatment Planning. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Phenylketonuria Genetic Testing Market

The continuous growth of mandatory newborn screening programs in both developing and developed regions significantly boosts the demand for effective phenylketonuria genetic testing. Early detection plays a crucial role in facilitating timely dietary interventions, leading to enhanced long-term health outcomes. As healthcare providers and public health agencies emphasize the need for accurate and rapid diagnostics, laboratories are increasingly adopting advanced testing technologies. This integration of genetic testing into standard healthcare practices not only propels market growth but also ensures a consistent volume of tests that encourages further investment in technological advancements and expands distribution networks.

Restraints in the Global Phenylketonuria Genetic Testing Market

The financial burden of advanced phenylketonuria testing kits, which often include proprietary reagents and specialized apparatus, presents a significant obstacle for numerous healthcare providers, particularly in resource-limited environments. Budget constraints compel institutions to focus on essential healthcare services, frequently resulting in limited funding for regular genetic screening initiatives. This heightened cost sensitivity diminishes the frequency of test orders and hampers the potential for market expansion into smaller clinics, thereby impeding overall market growth. Additionally, the substantial initial capital required for laboratory infrastructure can dissuade new market entrants, contributing to a gradual developmental pace within the industry.

Market Trends of the Global Phenylketonuria Genetic Testing Market

The Global Phenylketonuria Genetic Testing market is experiencing significant growth driven by the increasing adoption of personalized screening programs. Healthcare providers are incorporating genetic testing for phenylketonuria into newborn screening initiatives, which enables early detection and tailored dietary management plans for at-risk infants. Advances in DNA sequencing technology and data analytics facilitate proactive care pathways, aligning with the shift towards precision medicine. This surge in demand for comprehensive PKU testing kits is propelling market expansion, as well as encouraging partnerships and collaborative research efforts worldwide, ultimately working towards improved long-term health outcomes for individuals affected by this genetic disorder.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Phenylketonuria Genetic Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Newborn Screening
• Carrier Testing
• Prenatal Testing
• Diagnostic Testing

Global Phenylketonuria Genetic Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR
• Next-Generation Sequencing
• Sanger Sequencing
• Microarray

Global Phenylketonuria Genetic Testing Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood
• Amniotic Fluid
• Buccal Cells

Global Phenylketonuria Genetic Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Genetic Testing Centers

Global Phenylketonuria Genetic Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnosis
• Carrier Identification
• Prenatal Assessment
• Treatment Planning

Global Phenylketonuria Genetic Testing Market Size & CAGR (2026-2033)

• North America (Test Type, Technology, Sample Type, End User, Application)
  • US
  • Canada
• Europe (Test Type, Technology, Sample Type, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Technology, Sample Type, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Technology, Sample Type, End User, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Technology, Sample Type, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Labcorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centogene N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fulgent Genetics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baylor Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sema4
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blueprint Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PreventionGenetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambry Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayo Clinic Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMarin Pharmaceutical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revive Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations